Researchers are reporting a link between a Breast Cancer gene - BRCA1 - and Alzheimer’s disease.
Scientists have know for 2 decades that the gene BRCA1 (official name breast cancer 1) is a contributor to breast and ovarian.
Researchers at Gladstone Institutes have now shown that the protein BRCA1 is required for
normal learning and memory and is depleted by Alzheimer's disease.
|Subscribe to the Alzheimer's Reading Room|
These new findings suggest that a depletion of BRCA1 protein in neurons impairs brain cell function, contributing to cognitive deficits that are characteristic of Alzheimer’s disease. The findings are published in Nature Communications.
DNA Repair Protein BRCA1 Implicated in Cognitive Function and Dementia
- BRCA1 is a key protein involved in DNA repair, and mutations that impair its function increase the risk for breast and ovarian cancer. The new study demonstrates that Alzheimer’s disease is associated with a depletion of BRCA1 in neurons and that BRCA1 depletion can cause cognitive deficits.
- In dividing cells, BRCA1 helps repair a type of DNA damage known as double-strand breaks that can occur when cells are injured.
- In neurons, though, such breaks can occur even under normal circumstances, for example, after increased brain activity.
- The researchers speculated that in brain cells, cycles of DNA damage and repair facilitate learning and memory, whereas an imbalance between damage and repair disrupts these functions.
- To test this idea, the scientists experimentally reduced BRCA1 levels in the neurons of mice.
- Reduction of the DNA repair factor led to an accumulation of DNA damage and to neuronal shrinkage.
- It also caused learning and memory deficits.
They therefore analyzed neuronal BRCA1 levels in post-mortem brains of Alzheimer's patients.
- Compared with non-demented controls, neuronal BRCA1 levels in the patients were reduced by 65-75%.
- To determine the causes of this depletion, the investigators treated neurons grown in cell culture with amyloid-beta proteins, which accumulate in Alzheimer brains.
- These proteins depleted BRCA1 in the cultured neurons, suggesting that they may be an important cause of the faulty DNA repair seen in Alzheimer brains.
They are now testing whether increasing BRCA1 levels in these mouse models can prevent or reverse neurodegeneration and memory problems.
"Therapeutic manipulation of repair factors such as BRCA1 may ultimately be used to prevent neuronal damage and cognitive decline in patients with Alzheimer's disease or in people at risk for the disease," says senior author Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
"By normalizing the levels or function of BRCA1, it may be possible to protect neurons from excessive DNA damage and prevent the many detrimental processes it can set in motion."The researchers are continuing to investigate whether increasing BRCA1 levels can prevent or reverse neurodegeneration and memory problems and are beginning testing in a model for Alzheimer’s disease.
Custom Searches of the Alzheimer's Reading Room
Stages of Alzheimer's
You are reading original content the Alzheimer's Reading Room